Researchers’ Doubts About Nicotine Replacement Therapy Threaten Coverage
This article was originally published in The Tan Sheet
Executive Summary
Nicotine replacement therapy sales could take a hit if health policy makers heed advice not to increase coverage for the products at the expense of other allegedly more effective interventions. A recent study found NRT is no more effective in helping people quit smoking than going cold turkey.
You may also be interested in...
Smoking Cessation Savings Outweigh Costs Of Subsidies - Study
A 1study showing that the financial benefits of government subsidies for smoking cessation programs outweigh their costs prompts advocates and researchers to urge Medicaid coverage for the products, which could boost product sales
Medicaid Coverage For Smoking Cessation Gains Steam
An amendment proposed for the Senate's health care reform legislation follows the House in covering comprehensive smoking-cessation services, including OTC products, across the Medicaid community
J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.